A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer.
Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, Wang ZW, Zhang X, Tang M, Song MM, Zhang XW, Yang M, Chen YB, Yu KY, Deng L, Gong YZ, Hu W, Wang KH, Cong MH, Shi HP.
Ruan GT, et al. Among authors: zhang q, zhang xw, zhang x, zhang hy.
Front Endocrinol (Lausanne). 2022 Jun 20;13:905266. doi: 10.3389/fendo.2022.905266. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 35795140
Free PMC article.
Clinical Trial.